Infection Surveillance Solutions Market (By Product and Services - Software [ On-premise, Web-based], Services; By Infection Type - Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use - Long Term Care Facilities, Hospitals, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction 
 
Healthcare associated Infections (HAIs), or nosocomial contaminations, are the measure of the patient prosperity and health concerns coming about because of poor cleanliness, diminished patient immunity, carelessness and extra medicinal services uses. Infection surveillance is designed to constantly monitor information of HAIs for early detection of diseases and execution of preventive measures. Infection surveillance solutions are the projects, which helps in powerful administration of the Healthcare associated Infections (HAIs) in healthcare facilities. Pneumonia, urinary tract diseases, gastrointestinal sickness, blood infections are the few noteworthy HAIs. High rates of HAIs are the real concern for government over the globe, and thus, different governments have focused on policies to successfully oversee and diminish rates of HAIs. The report provides analysis of global infection surveillance solutions market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. The global infection surveillance solutions market is anticipated to grow at considerable CAGR above 14.0% over the forecast period and reach around US$ 1.32 Bn by 2026. 
 
Market Dynamics
 
The factors driving the growth of the infection surveillance solution are increment in rate of HAIs, growth in number of medical procedures, government initiatives for the prevention of HAIs and rise in global healthcare infrastructure spending. Growth in the number of medical procedures performed worldwide has prompted to increased stays in hospitals. Therefore, number of instances of patients experiencing HAIs is increasing globally. This is evaluated to supplement the market growth. Widespread occurrence of infectious diseases is the primary factor to boost the growth of the market. Moreover, introduction of advanced version of infection surveillance solutions is anticipated to propel the growth of global infection surveillance solutions.
 
Market Segmentation

Market by Product and Services

  • Software
    • On-premise
    • Web-based
  • Services

Market by Infection Type

  • Surgical Site Infections (SSI)       
  • Blood Stream Infections (BSI)
  • Urinary Tract Infections (UTI)
  • Others      

Market by End-Use

  • Long Term Care Facilities
  • Hospitals
  • Others (Clinics, and Ambulatory Surgical Centers)  

Market by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA
The market research study on “Infection Surveillance Solutions Market (By Product and Services - Software [ On-premise, Web-based], Services; By Infection Type - Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use - Long Term Care Facilities, Hospitals, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026” offers a detailed insights on global infection surveillance solutions market focusing on insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global infection surveillance solutions market by product and services, infection type, end-use and major geographic regions. The report also covers basic healthcare development policies. 

Report Coverage

Market

Infection Surveillance Solutions Market

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Intervention, Distribution method and Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

 
Market Participants
 
The company profiling of key players in the global Infection surveillance solutions Becton Dickinson and Compan,, Premier Inc., Wolters Kluwer N.V, Gojo Industries, Baxter International Inc., RL Solutions, Truven Health Analytics and Premier Inc.market includes company overview, major business strategies and revenues. 
 


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary